XML 38 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

Revenue (Tables) | 3 Months Ended
--- | ---
Mar. 28, 2025
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three-month periods ended March 28, 2025 and March 29, 2024 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
| Biotechnology |  | Life Sciences |  | Diagnostics |  | Total
For the Three-Month Period Ended March 28, 2025: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America(a) | $ | 543 |  |  | $ | 721 |  |  | $ | 1,318 |  |  | $ | 2,582 |
Western Europe | 566 |  |  | 378 |  |  | 400 |  |  | 1,344 |
Other developed markets(b) | 64 |  |  | 123 |  |  | 91 |  |  | 278 |
High-growth markets(c) | 439 |  |  | 458 |  |  | 640 |  |  | 1,537 |
Total | $ | 1,612 |  |  | $ | 1,680 |  |  | $ | 2,449 |  |  | $ | 5,741 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 1,457 |  |  | $ | 1,136 |  |  | $ | 2,223 |  |  | $ | 4,816 |
Nonrecurring | 155 |  |  | 544 |  |  | 226 |  |  | 925 |
Total | $ | 1,612 |  |  | $ | 1,680 |  |  | $ | 2,449 |  |  | $ | 5,741 |
For the Three-Month Period Ended March 29, 2024: |  |  |  |  |  |  |
Geographical region: |  |  |  |  |  |  |
North America(a) | $ | 514 |  |  | $ | 781 |  |  | $ | 1,337 |  |  | $ | 2,632 |
Western Europe | 546 |  |  | 372 |  |  | 406 |  |  | 1,324 |
Other developed markets(b) | 79 |  |  | 125 |  |  | 99 |  |  | 303 |
High-growth markets(c) | 385 |  |  | 467 |  |  | 685 |  |  | 1,537 |
Total | $ | 1,524 |  |  | $ | 1,745 |  |  | $ | 2,527 |  |  | $ | 5,796 |
Revenue type: |  |  |  |  |  |  |
Recurring | $ | 1,309 |  |  | $ | 1,192 |  |  | $ | 2,294 |  |  | $ | 4,795 |
Nonrecurring | 215 |  |  | 553 |  |  | 233 |  |  | 1,001 |
Total | $ | 1,524 |  |  | $ | 1,745 |  |  | $ | 2,527 |  |  | $ | 5,796 |
(a) The Company defines North America as the United States and Canada. (b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets. (c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration